CMEOUTfitters Logo in partnership with CMEmaster Logo


ACCME Logo ACCME Accredited Free CME Activity on COVID-19

Bench to Bedside OnDemand

The Growing (Anti)body of Evidence for the Treatment of Mild-to-Moderate COVID-19

Register Now

Earn a maximum of
1.5 AMA PRA Category 1 Credit(s)TM

Credit Expiration Date Thursday, May 12, 2022
Duration of the course 1.5 hours
Certificate : Apply for CME credit or Participation
Course Details Bench to Bedside OnDemand: The Growing (Anti)body of Evidence for the
Treatment of Mild-to-Moderate COVID-19

This free, 90-minute CME credit activity is brought to you in partnership between CMEOutfitters and HealthMinds. The activity was premiered on Wednesday, May 12, 2021 and is designated with Accreditation Council for Continuing Medical Education (ACCME) credits of maximum of 1.5 AMA PRA Category 1 CreditTM

The novel SARS-CoV-2 virus caused the rapid global spread of COVID-19, and while coronavirus is often mild and self-limiting, approximately 10% of mild SARS-CoV-2 infections progress to severe symptoms, including respiratory distress syndrome, and up to 20% of symptomatic patients develop critical disease with clinical complications including pneumonia and hyper- inflammation. Several repurposed drugs have been used to treat patients hospitalized with serious COVID-19 disease, with neutralizing monoclonal antibodies (nAbs) being one of the first therapies offered by the FDA. But despite promising results, the demand for treatment for mild-to-moderate COVID-19 has not met expectations, as many health care providers may not be familiar with or aware that preventative treatments are available for mild-to-moderate COVID-19.

This activity on early intervention treatments following diagnosis of COVID-19 as a way to reduce progression to severe disease will include the latest data on the efficacy and safety of nAb therapies and strategies for addressing knowledge and practice barriers to improve patient access to these therapies.

Learning Objectives Of The Course
  1. Integrate screening assessments for the early and accurate diagnosis of mild-to-moderate COVID-19 to guide treatment decision- making in high-risk patient groups

  2. Apply the latest data on the efficacy and safety of nAb therapies to treatment decisions for patients with mild-to-moderate COVID-19

  3. Implement strategies to address knowledge and practice barriers to patient access to infusion service for nAb therapy
Finance Support

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.

Target audience

Physicians, PAs, nurse practitioners, nurses, infusion center nurses, and pharmacists

Our Faculty
Eminent Healthcare Leaders
Dr Peter Chen, MD
Professor of Medicine and Biomedical Sciences Director, Division of Pulmonary and Critical Care Medicine Cedars-Sinai Medical Center Los Angeles, CA
Dr Gregory D. Huhn, MD, MPHTM
COVID-19 Vaccination Coordinator and Senior Director of HIV Services Cook County Health Associated Professor, Department of Internal MedicineDivision of Infectious Disease Rush University Medical Center Chicago, IL
Chair and Associate Professor Department of Family and Community Medicine Lewis Katz School of Medicine at Temple University Philadelphia, PA
Accreditation and designation statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CME Outfitters, LLC and CME Master. CME Outfitters, LLC is accredited by the ACCME to provide continuing medical education for physicians.

CME Outfitters, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure statement

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.